(Q54747960)

3 June 2018

title

Polyclonal CTL Responses Observed in Melanoma Patients Vaccinated with Dendritic Cells Pulsed with a MAGE-3.A1 Peptide (English)

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4893

23 March 2024

1 reference

immunologic cytotoxicity

1 reference

PubMed ID

14568970

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14568970

23 March 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4893

23 March 2024

author

Beatrice Schuler-Thurner

5

object named as

Beatrice Schuler-Thurner

1 reference

3 June 2018

author name string

Danièle Godelaine

1

1 reference

3 June 2018

Javier Carrasco

2

1 reference

3 June 2018

Sophie Lucas

3

1 reference

3 June 2018

Vaios Karanikas

4

1 reference

3 June 2018

Gerold Schuler

7

1 reference

3 June 2018

Thierry Boon

8

1 reference

3 June 2018

Aline Van Pel

9

1 reference

3 June 2018

Pierre G. Coulie

6

1 reference

PubMed ID

14568970

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14568970

23 March 2024

language of work or name

English

0 references

publication date

1 November 2003

1 reference

3 June 2018

published in

Journal of Immunology

1 reference

3 June 2018

volume

171

1 reference

3 June 2018

page(s)

4893-4897

1 reference

3 June 2018

issue

9

1 reference

3 June 2018

Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes

cites work

2

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4893

A MAGE-3 peptide recognized on HLA-B35 and HLA-A1 by cytolytic T lymphocytes

23 March 2024

3

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4893

Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1

23 March 2024

4

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4893

A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3.

23 March 2024

5

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4893

Monoclonal Anti-MAGE-3 CTL Responses in Melanoma Patients Displaying Tumor Regression after Vaccination with a Recombinant Canarypox Virus

23 March 2024

6

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4893

The dendritic cell system and its role in immunogenicity

23 March 2024

7

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4893

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

23 March 2024

8

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4893

Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. II. T lymphocyte-mediated cytolysis

23 March 2024

9

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4893

An experimentally validated panel of subfamily-specific oligonucleotide primers (V alpha 1-w29/V beta 1-w24) for the study of human T cell receptor variable V gene segment usage by polymerase chain reaction

23 March 2024

10

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4893

The sizes of the CDR3 hypervariable regions of the murine T-cell receptor beta chains vary as a function of the recombined germ-line segments

23 March 2024

11

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4893

Estimation of the frequencies of anti-MAGE-3 cytolytic T-lymphocyte precursors in blood from individuals without cancer.

23 March 2024

12

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4893

23 March 2024

Identifiers

1 reference

3 June 2018

PubMed ID

14568970

1 reference

3 June 2018